06 Dec Global design and innovation firm IDEO is designing the experience of taking a narcolepsy medication
IDEO is working with a pharmaceutical company to re-think and re-design the experience of taking...
05 Dec Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in CONCERT Phase 2 Trial in Narcolepsy
NEW YORK, Dec. 03, 2019 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage...
23 Nov Wake Up Narcolepsy Launches a WUN Narcolepsy Awareness Apparel Fundraiser!
Wake Up Narcolepsy launched a WUN Narcolepsy Awareness Apparel Fundraiser in conjunction with their 2019...
21 Nov Wake Up Narcolepsy attends a Sleep Community Capitol Hill Advocacy Day in Washington DC
On Tuesday, November 19, 2019, Wake Up Narcolepsy joined Project Sleep, the Sleep Research Society...
21 Nov Harmony Biosciences Announces Publication Of Data In Sleep From Two Clinical Studies Of WAKIX® (pitolisant)
Harmony Biosciences has published two informative clinical studies evaluating the long-term safety and efficacy, as...
20 Nov A New Pediatric Narcolepsy Research Survey Open
Calling all adolescents with narcolepsy, parents, and medical providers: Wake Up Narcolepsy, in collaboration with researchers,...
13 Nov WUN Receives a “Celebration of Donors” Plaque from the SickKids Foundation
For the past 8 years Wake Up Narcolepsy has taken portions of funds raised during...
04 Nov Wakix is a Newly Approved Treatment for Excessive Daytime Sleepiness (EDS)
Great News! Wakix is a newly approved treatment for Excessive Daytime Sleepiness (EDS) and as a...
26 Sep Jazz Pharmaceuticals Presents Positive JZP-258 Phase 3 Study Data at World Sleep 2019
JZP-258 achieves primary and key secondary endpoints demonstrating highly statistically significant differences in weekly number...
22 Sep Harmony Biosciences Announces Recipients of 2019 Patients at the Heart Grant in Recognition of World Narcolepsy Day
Four organizations will receive grants totaling $65,000 to support programs that help address unmet needs...